Present evidence indicates that proteinuria in patients with the nephrotic syndrome is the result of increased permeability of the glomerular capillary walls to proteins, particularly to albumin (1, 2). A rough indication of the permeability to albumin, relative to permeability to water, is provided by the ratio of the concentration of albumin in glomerular fluid to that in plasma. Assuming that no albumin is excreted by the tubules, the rate of albumin excretion (in mg. per min.) divided by the rate of glomerular filtration of water (GFR, in ml. per min.) represents the lowest possible concentration of albumin in glomerular fluid (in mg. per ml.) ; if some albumin is reabsorbed by the tubules, as seems likely, the actual concentration of albumin in glomerular fluid would be greater than this calculated value. If it is accepted that the clearance of inulin (CIN) is equivalent to GFR in children with the nephrotic syndrome (3), it follows that the renal clearance of albumin (CALB) divided by CIN, i.e., CALB/CIN, represents the minimum ratio of the albumin concentration in glomerular fluid to that in plasma. Chinard, Lauson, and Eder (4) showed that in patients with the nephrotic syndrome the renal clearance of the blue dye, T-1824 (CT_1824), was somewhat less than but approximately proportional to CALB. It would appear, therefore, that where large changes in permeability are expected CT_1824
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Chinard, Lauson, and Eder (4) showed that in patients with the nephrotic syndrome the renal clearance of the blue dye, T-1824 (CT_1824), was somewhat less than but approximately proportional to CALB. It would appear, therefore, that where large changes in permeability are expected CT_1824
should be a satisfactory substitute for CALB. The methods for determining concentrations of the dye in serum and urine (4) are much easier than the immunochemical method for albumin (1, 5) .
In many patients with the nephrotic syndrome, proteinuria diminished during or after treatment with corticotropin (ACTH) or Cortisone (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Further, in most patients so treated GFR increased (6) (7) (8) 12 ). These observations suggested that glomerular permeability to albumin decreased under the influence of treatment. The present study was undertaken to estimate the order of magnitude of this change in permeability. A preliminary report of this work has been previously published (18 (19) . After 10 minutes a venous blood sample was withdrawn (B1). Another aliquot of dye was delivered by the same pipette into a volumetric flask, the volume of which was roughly one-fifth of the expected plasma volume. This, filled to the mark with physiologic saline, was the "reference solution" (20) . Several minutes later the bladder was washed out with air and the urine saved for total protein determination in most observations. The urine for estimation of CT-13 (U1) was collected 10 to 31 minutes later; another blood sample (B2) was taken soon thereafter. Priming doses of inulin and PAH were next injected intravenously, and a sustaining infusion of these substances in physiologic saline was administered at a rate of 0.5 ml. per min. by means of a Bowman constant infusion pump. After an equilibration period of about one hour, three urine collections were made, each of 10 -to 20 minutes duration (U2-4) (21) of serum and in suitably diluted urine was determined by the method of Schreiner (22) . Omitting precipitation of protein in these urines introduced no error in the inulin determination of more than 2 per cent. The concentration of PAH, also in cadmium filtrates of serum and diluted, unprecipitated urine, was determined by a modification of the method of Bratton and Marshall (21) .
Specific endogenous creatinine was determined by a modification of the method of Hare (23) . In the earlier cases, serum protein was precipitated (1: 5) by the tungstic acid method of Wu (24) , and the urine protein was not precipitated. Later, the proteins of both serum and urine were precipitated (1: 5) by trichloroacetic acid. Ten ml. aliquots of serum filtrates and of diluted urine, as well as the standard solutions of creatinine zinc chloride, were all made up to contain 5 per cent trichloroacetic acid. One ml. of saturated oxalic acid and approximately 40 mg. of Lloyd's reagent were added. After frequent shaking during a 10-minute period the solution was centrifuged and the supernate carefully aspirated. The creatinine adsorbed to Lloyd's reagent was eluted by adding 5 ml. of alkaline picrate (Hare's formula [23] ) and shaking frequently during a 10-minute period.-After centrifugation the clear supernate was transferred with a Wintrobe pipette to an 18 X 150 mm. cuvette; the optical density was read in a Coleman Model 6A clinical spectrophotometer at a wave length setting of 500 mi. A portion of the light aperture of the cuvette holder was blocked off by black cellophane tape. By eluting the creatinine from 10 ml. of serum filtrate into 5 ml. of alkaline picrate an additional two-fold concentration was achieved (in effect, the serum creatinine was diluted only 1: 2.5). Thus the very low concentrations frequently encountered in small children (i.e., as little as 0.15 to 0.20 mg. per 100 ml. of serum) could be estimated with satisfactory accuracy. The concentrations in two or three successive serum samples were averaged and this average value was used in calculating CCB for all periods.
T-1824 in the serum was estimated by the acetone extraction procedure of Chinard and Eder (20) . The concentration of dye in urine clarified by centrifugation was determined by a modification of the method of Chinard, Lauson, and Eder (4). All urines were buffered with 0.5 ml. of M phosphate buffer, pH 7.0, and if necessary diluted with physiologic saline. Final volumes varied from 2 to 5 ml. Because the urinary blank was often relatively large, and because the dye excretion was usually quite low after ACTH, several "corrections" were made to secure maximum accuracy in calculating CT-... Optical density was read both at 620 mi and 450 mn, the instrument being set to zero optical density with a control solution of saline and buffer.5 The "corrected" optical density at 620 mis of U1 in the pre-ACTH study was calculated by the equation:
where Duo and Duo are the optical density of U1 at 620 mys and 450 miy, respectively; K1 is the optical density at X = 620 mjn of the control urine (UO) of the pre-ACTH study divided by its optical density at X = 450 mys; K2 is the increment in optical density at X = 620 mis divided by that at X = 450 my due to addition of a known amount of dye to UO (i.e., the optical density of Uo at each wavelength was subtracted from that of [UO + dye]). "Corrected" concentration in U1 was calculated as:
X concentration of dye in (U0 + dye) X dilution factor of Ui.
"Corrected" dye excretion is the product of the concentration and urine flow.' 5 Under the conditions of the studies reported here the molar concentration ratios of albumin to dye in the plasma, and therefore also in the glomerular filtrate, were well within the range of 1: 1 to 1: 100. Therefore, it may reasonably be assumed that variations in the absorption coefficient of the dye in the urines were relatively unitnportant (4) . 6An example will make clear how these corrections were applied. In patient W. H. (2-7-51), the optical densities of-U0 and U1 at X = 620 m,u were 0.013 and 0.270, respectively; at X = 450 mp, optical densities of Uo and U1 were 0.071 and 0.099, respectively. The optical density of (U0 + dye) at X = 620 mu was 0.449 and at In the subsequent studies on each patient, there was often a small residual excretion of T-1824, due to dye administered during the preceding study.7 For this reason, additional calculations were necessary. K1 of the first study was inserted in the equation and the "corrected" DM and concentration were calculated for UO as well as Ui. Multiplying the concentrations (in Ag. per ml.) by the respective urine flow rates, V (in ml. per min.), the corrected excretion rates, UV, for T-1824 were obtained (in /Ag. per min.). To reduce errors which might have arisen from improper bladder emptying or change in GFR, the following calculation was made:
To calculate CT-_, the "corrected" excretion rate was divided by the concentration in serum interpolated at the midpoint of UL from a semi-logarithmic plot of the concentrations in the serum of B1 and B2. The optical density of the control serum (Bo) of the same day was subtracted from that of the two dye-stained sera. Usually this correction was negligible (less than 0.003 optical density units).
Plasma and whole blood volumes were calculated in the manner described by Chinard and Eder (20) . Total protein concentration in the urine of the control period immediately preceding U1 was determined by the biuret method of Hiller, Greif, and Beckman (25) . In a few cases, the clearance of albumin and CT-182 were ml.; U1 had been diluted 1:4. Urine flow during U, was 0.136 ml. per min. The "corrected" optical density of U, ,ug./ml, X 4 = 23.0 jug./ml. "Corrected" U1V1 = 23.0 X 0.136 = 3.13 ,g./min. The interpolated midpoint concentration in serum was 17.1 Ag./ml. Hence CT-1824 = 0.183 ml. per min. 7 In one of the subsequent studies, the control urine had a distinctly blue color. After centrifugation, most of the color was found concentrated in the sediment; microscopically, most of the dye could be seen in urinary tract epithelial cells, presumably in desquamated renal tubule epithelium. The dye slowly diffused from the cells on repeated extraction with physiological saline. Routinely, all urine specimens were centrifuged about one hour after the last clearance period preparatory to determining the dye concentration. It is assumed that the amount of dye diffusing from the cells of the sediment during the interval before centrifugation contributed about the same amount of dye (expressed as uig. per minute) to the control urine (U0) as to subsequent urines; the resulting errors would, therefore, approximately cancel. In several other observations, the amount of dye concentrated in the sediment was much less than in the one described. estimated concurrently to learn if the proportionality observed by Chinard, Lauson, and Eder (4) obtained under the conditions of the present studies, i.e., during or after ACTH therapy. The immunochemical method used to estimate albumin concentration in urine and plasma was essentially that described by Kunkel and Ward (5) . In the present investigation, however, twice-crystallized human plasma albumin was used as the antigen.8
RESULTS
The data are summarized in Tables I and II and Figure 1 .
Inulin clearance
The inulin clearance rose at least slightly in most of the patients either during or, more often, after the ACTH treatment as reported previously by other workers (7, 8, 12) . When initially subnormal, this function often rose to normal; if initially normal, it tended to become supernormal.
Creatinine clearance
As was first shown by Miller and Winkler (26) and subsequently confirmed by others (3, 8, 27) , the specific endogenous creatinine clearance exceeded the inulin clearance before ACTH treatment; the highest value of the ratio, CCR/CIN, was 2.65. During and after ACTH therapy, usually in association with a rise in both clearances, the ratio decreased toward the normal value of 1.0 as described previously (8).
T-1824 clearance
In all patients, the dye clearance decreased markedly during and after treatment whether the inulin clearance increased or not. Expressed as the ratio, Cr-1824/CIN, the effect was striking; in all but two cases the decrease was 10-fold or more.
Comparison of simultaneously measured clearances of T-1824 and albumin The data are summarized in Table II . Technical difficulties were encountered in the immunochemical determination of albumin. Furthermore, the very low urinary concentrations of albumin and dye in the post-ACTH periods undoubtedly re- Data from control period preceding period U1.
Calculated by dividing the value in column 22 by the estimated CIN. The latter was estimated by dividing the observed COR by the value for mean CcR,/CIN shown in column 17.
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Datum from study of 4-6-51. tained by the present data (Table I) . More often were recently discussed by Chinard, Lauson, Eder, than not, the plasma volume did not increase sig-Greif, and Hiller, (1) and reviewed by Smith (28) nificantly.
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To the extent that the ratio, CTQ1824/CIN, estimates the ratio, CALB/CIN, and to the extent that the latter provides a rough indication of the minimum permeability of the glomerular walls to albumin, relative to the permeability to water, the data of the present investigation clearly indicate that treatment with ACTH (and presumably also with Cortisone) results in a marked degree of reversal of the functional pathology in the glomeruli. The usual increase in GFR may be considered another aspect of this same restorative process. As discussed in detail elsewhere (2) , it is our present opinion that these effects on the glomeruli are primary and that most of the other beneficial effects of the treatment are secondary.
SUMMARY
Simultaneous renal clearances of the blue dye, T-1824 (CT-1824), and of albumin (CALB) have been shown to be nearly the same in patients with the nephrotic syndrome (4). Furthermore, the ratio of the clearances of albumin and inulin (CALB/CIN) provides a rough indication of the minimum glomerular permeability to albumin, relative to the permeability to water.
In 10 edematous children with the nephrotic syndrome the ratio, CTA1824/CIN, ranged from 0.26 to 3.8 ml. per 100 ml. before treatment with corticotropin (ACTH). Glomerular filtration rate (GFR), as estimated by CIN, ranged from 15 to 134 per cent of average normal. From 50 to 100 mg. of ACTH per day were given intramuscularly in divided dosage every six hours for from four to ten days. By the end of, or a few days after, the course of injections, CT_1824/CIN had decreased strikingly in all patients: more than 10-fold in all but two. CIN increased at least slightly in most cases and more than doubled in four. Similar results were observed in one non-edematous boy with chronic glomerular nephritis who excreted only 1 to 2 grams of protein per day. In the control study, CT_1824/CIN was only 0.07 ml. per 100 ml.; after ACTH it had decreased to 0.006 ml. per 100 ml.
The data of this investigation are interpreted as indicating that one of the favorable effects of ACTH treatment is a reversal toward normal of :I the increased glomerular permeability to albumin (and other plasma proteins). The same restorative process is presumably responsible for some of the observed increase in GFR. These effects of therapy on the glomeruli are considered to be primary to most of the other beneficial results.
